Experienced Professional to Focus on Building European Clinical Development and Ensuring Patient Safety
Zurich, Switzerland and Morrisville, NC (Business Wire) November 2, 2011 — Clinipace Worldwide, a global digital contract research organization (dCRO) that has pioneered technology-amplified contract research services, announced today the promotion of Andrea Schiefer, PhD to Vice President of European Clinical Operations and Executive Director of Pharmacovigilance.
In this position, Andrea reports directly to Kurt Pfister, Chief Executive Officer of European Operations at Clinipace Worldwide, and is responsible for providing leadership and direction to the project management, clinical monitoring and safety groups within the European clinical operations unit at Clinipace Worldwide.
Prior to joining Clinipace Worldwide in May 2011, Andrea held several senior management positions at contract research organizations including Medpace GmbH, TNS Healthcare, and Quintiles GmbH.
Andrea completed her PhD in neurobiology from the University of Düsseldorf, followed by a two-year post-doctorate fellowship in endocrinology at J. Gutenberg University. Additionally, Andrea holds a degree in pharmacy from the University of Frankfurt and is licensed to practice pharmacy in Germany.
“Andrea’s expertise with managing clinical development programs throughout Europe and deep understanding of patient safety regulations will ensure our clients receive excellent guidance and service as they conduct clinical trials across the continent,” said Kurt Pfister, Chief Executive Officer of European Operations at Clinipace Worldwide.
About Clinipace Worldwide
Clinipace Worldwide, a global digital contract research organization (dCRO), specializes in fully-integrated contract research services for biopharmaceutical and medical device firms. Optimized by TEMPO™, its proprietary eClinical platform, the Clinipace team of experts brings extensive knowledge and insight into site selection, patient recruitment, clinical operations, data management, medical monitoring, biostatistics, and regulatory affairs to ensure a successful clinical development program through proactive clinical trial management. With specific expertise in oncology, among other therapeutic areas, Clinipace Worldwide has managed over 500 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Overland Park, Kansas, Boulder, Colorado, Zurich, Switzerland, Munich, Germany, Tel-Aviv, Israel, New Delhi, India, Sao Paulo, Brazil, Buenos Aires, Argentina, and Lima, Peru. For more information visit our website at www.clinipace.com.